Cornercap Investment Counsel Inc Precision Biosciences Inc Transaction History

Cornercap Investment Counsel Inc

  • $329 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.97 - $45.0 $1,234 - $57,285
1,273 Added 0.96%
134,273 $159,000
Q3 2022

Nov 14, 2022
BUY
$1.22 - $40.8 $73,323 - $2.45 Million
60,101 Added 82.44%
133,000 $173,000
Q2 2022

Aug 15, 2022
BUY
$1.15 - $3.34 $83,833 - $243,482
72,899 New
72,899 $117,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $539M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email